Global Breast Cancer Liquid Biopsy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Breast Cancer Liquid Biopsy market size was valued at USD 1643.7 million in 2023 and is forecast to a readjusted size of USD 2280 million by 2030 with a CAGR of 4.8% during review period.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
The Global Info Research report includes an overview of the development of the Breast Cancer Liquid Biopsy industry chain, the market status of Hospitals (Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), Diagnostic Centers (Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Breast Cancer Liquid Biopsy.
Regionally, the report analyzes the Breast Cancer Liquid Biopsy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Breast Cancer Liquid Biopsy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Breast Cancer Liquid Biopsy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Breast Cancer Liquid Biopsy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Breast Cancer Liquid Biopsy market.
Regional Analysis: The report involves examining the Breast Cancer Liquid Biopsy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Breast Cancer Liquid Biopsy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Breast Cancer Liquid Biopsy:
Company Analysis: Report covers individual Breast Cancer Liquid Biopsy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Breast Cancer Liquid Biopsy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Breast Cancer Liquid Biopsy. It assesses the current state, advancements, and potential future developments in Breast Cancer Liquid Biopsy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Breast Cancer Liquid Biopsy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Breast Cancer Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Breast Cancer Liquid Biopsy, with revenue, gross margin and global market share of Breast Cancer Liquid Biopsy from 2019 to 2024.
Chapter 3, the Breast Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Breast Cancer Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Breast Cancer Liquid Biopsy.
Chapter 13, to describe Breast Cancer Liquid Biopsy research findings and conclusion.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
The Global Info Research report includes an overview of the development of the Breast Cancer Liquid Biopsy industry chain, the market status of Hospitals (Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), Diagnostic Centers (Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Breast Cancer Liquid Biopsy.
Regionally, the report analyzes the Breast Cancer Liquid Biopsy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Breast Cancer Liquid Biopsy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Breast Cancer Liquid Biopsy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Breast Cancer Liquid Biopsy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Breast Cancer Liquid Biopsy market.
Regional Analysis: The report involves examining the Breast Cancer Liquid Biopsy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Breast Cancer Liquid Biopsy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Breast Cancer Liquid Biopsy:
Company Analysis: Report covers individual Breast Cancer Liquid Biopsy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Breast Cancer Liquid Biopsy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Breast Cancer Liquid Biopsy. It assesses the current state, advancements, and potential future developments in Breast Cancer Liquid Biopsy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Breast Cancer Liquid Biopsy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Circulating Tumor Cells (CTCs)
- Cell-Free DNA (CfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- Hospitals
- Diagnostic Centers
- Laboratories
- QIAGEN
- Roche Diagnostics
- Bio-Rad Laboratories
- Myriad Genetics
- Menarini Silicon Biosystems
- Genomic Health
- Thermo Fisher Scientific
- Illumina
- Biocept
- Trovagene
- Guardant Health
- RainDance Technologies
- MDx Health
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Breast Cancer Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Breast Cancer Liquid Biopsy, with revenue, gross margin and global market share of Breast Cancer Liquid Biopsy from 2019 to 2024.
Chapter 3, the Breast Cancer Liquid Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Breast Cancer Liquid Biopsy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Breast Cancer Liquid Biopsy.
Chapter 13, to describe Breast Cancer Liquid Biopsy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Breast Cancer Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Breast Cancer Liquid Biopsy by Type
1.3.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
1.3.3 Circulating Tumor Cells (CTCs)
1.3.4 Cell-Free DNA (CfDNA)
1.3.5 Extracellular Vesicles (EVs)
1.3.6 Other Circulating Biomarkers
1.4 Global Breast Cancer Liquid Biopsy Market by Application
1.4.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Diagnostic Centers
1.4.4 Laboratories
1.5 Global Breast Cancer Liquid Biopsy Market Size & Forecast
1.6 Global Breast Cancer Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Breast Cancer Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Breast Cancer Liquid Biopsy Market Size by Region, (2019-2030)
1.6.3 North America Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.4 Europe Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.6 South America Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 QIAGEN
2.1.1 QIAGEN Details
2.1.2 QIAGEN Major Business
2.1.3 QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
2.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 QIAGEN Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
2.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
2.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
2.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Menarini Silicon Biosystems
2.5.1 Menarini Silicon Biosystems Details
2.5.2 Menarini Silicon Biosystems Major Business
2.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
2.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business
2.6.3 Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
2.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Genomic Health Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
2.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Breast Cancer Liquid Biopsy Product and Solutions
2.8.4 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Biocept
2.9.1 Biocept Details
2.9.2 Biocept Major Business
2.9.3 Biocept Breast Cancer Liquid Biopsy Product and Solutions
2.9.4 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biocept Recent Developments and Future Plans
2.10 Trovagene
2.10.1 Trovagene Details
2.10.2 Trovagene Major Business
2.10.3 Trovagene Breast Cancer Liquid Biopsy Product and Solutions
2.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Trovagene Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
2.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 RainDance Technologies
2.12.1 RainDance Technologies Details
2.12.2 RainDance Technologies Major Business
2.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
2.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 RainDance Technologies Recent Developments and Future Plans
2.13 MDx Health
2.13.1 MDx Health Details
2.13.2 MDx Health Major Business
2.13.3 MDx Health Breast Cancer Liquid Biopsy Product and Solutions
2.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 MDx Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Breast Cancer Liquid Biopsy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Breast Cancer Liquid Biopsy by Company Revenue
3.2.2 Top 3 Breast Cancer Liquid Biopsy Players Market Share in 2023
3.2.3 Top 6 Breast Cancer Liquid Biopsy Players Market Share in 2023
3.3 Breast Cancer Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Breast Cancer Liquid Biopsy Market: Region Footprint
3.3.2 Breast Cancer Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Breast Cancer Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Breast Cancer Liquid Biopsy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Breast Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2024)
5.2 Global Breast Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
6.2 North America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
6.3 North America Breast Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
6.3.2 United States Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.3 Canada Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
7.2 Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
7.3.2 Germany Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.3 France Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.5 Russia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.6 Italy Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2030)
8.3.2 China Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.3 Japan Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.4 South Korea Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.5 India Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.7 Australia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
9.2 South America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
9.3 South America Breast Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
9.3.2 Brazil Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9.3.3 Argentina Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
10.3.2 Turkey Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.4 UAE Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Breast Cancer Liquid Biopsy Market Drivers
11.2 Breast Cancer Liquid Biopsy Market Restraints
11.3 Breast Cancer Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Breast Cancer Liquid Biopsy Industry Chain
12.2 Breast Cancer Liquid Biopsy Upstream Analysis
12.3 Breast Cancer Liquid Biopsy Midstream Analysis
12.4 Breast Cancer Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Breast Cancer Liquid Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Breast Cancer Liquid Biopsy by Type
1.3.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
1.3.3 Circulating Tumor Cells (CTCs)
1.3.4 Cell-Free DNA (CfDNA)
1.3.5 Extracellular Vesicles (EVs)
1.3.6 Other Circulating Biomarkers
1.4 Global Breast Cancer Liquid Biopsy Market by Application
1.4.1 Overview: Global Breast Cancer Liquid Biopsy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Diagnostic Centers
1.4.4 Laboratories
1.5 Global Breast Cancer Liquid Biopsy Market Size & Forecast
1.6 Global Breast Cancer Liquid Biopsy Market Size and Forecast by Region
1.6.1 Global Breast Cancer Liquid Biopsy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Breast Cancer Liquid Biopsy Market Size by Region, (2019-2030)
1.6.3 North America Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.4 Europe Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.6 South America Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Breast Cancer Liquid Biopsy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 QIAGEN
2.1.1 QIAGEN Details
2.1.2 QIAGEN Major Business
2.1.3 QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
2.1.4 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 QIAGEN Recent Developments and Future Plans
2.2 Roche Diagnostics
2.2.1 Roche Diagnostics Details
2.2.2 Roche Diagnostics Major Business
2.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
2.2.4 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Diagnostics Recent Developments and Future Plans
2.3 Bio-Rad Laboratories
2.3.1 Bio-Rad Laboratories Details
2.3.2 Bio-Rad Laboratories Major Business
2.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
2.3.4 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
2.4.4 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Menarini Silicon Biosystems
2.5.1 Menarini Silicon Biosystems Details
2.5.2 Menarini Silicon Biosystems Major Business
2.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
2.5.4 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Menarini Silicon Biosystems Recent Developments and Future Plans
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business
2.6.3 Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
2.6.4 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Genomic Health Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
2.7.4 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Breast Cancer Liquid Biopsy Product and Solutions
2.8.4 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Biocept
2.9.1 Biocept Details
2.9.2 Biocept Major Business
2.9.3 Biocept Breast Cancer Liquid Biopsy Product and Solutions
2.9.4 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Biocept Recent Developments and Future Plans
2.10 Trovagene
2.10.1 Trovagene Details
2.10.2 Trovagene Major Business
2.10.3 Trovagene Breast Cancer Liquid Biopsy Product and Solutions
2.10.4 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Trovagene Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
2.11.4 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 RainDance Technologies
2.12.1 RainDance Technologies Details
2.12.2 RainDance Technologies Major Business
2.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
2.12.4 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 RainDance Technologies Recent Developments and Future Plans
2.13 MDx Health
2.13.1 MDx Health Details
2.13.2 MDx Health Major Business
2.13.3 MDx Health Breast Cancer Liquid Biopsy Product and Solutions
2.13.4 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 MDx Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Breast Cancer Liquid Biopsy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Breast Cancer Liquid Biopsy by Company Revenue
3.2.2 Top 3 Breast Cancer Liquid Biopsy Players Market Share in 2023
3.2.3 Top 6 Breast Cancer Liquid Biopsy Players Market Share in 2023
3.3 Breast Cancer Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Breast Cancer Liquid Biopsy Market: Region Footprint
3.3.2 Breast Cancer Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Breast Cancer Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Breast Cancer Liquid Biopsy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Breast Cancer Liquid Biopsy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2024)
5.2 Global Breast Cancer Liquid Biopsy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
6.2 North America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
6.3 North America Breast Cancer Liquid Biopsy Market Size by Country
6.3.1 North America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
6.3.2 United States Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.3 Canada Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
6.3.4 Mexico Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
7.2 Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Country
7.3.1 Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
7.3.2 Germany Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.3 France Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.5 Russia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
7.3.6 Italy Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2030)
8.3.2 China Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.3 Japan Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.4 South Korea Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.5 India Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
8.3.7 Australia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
9.2 South America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
9.3 South America Breast Cancer Liquid Biopsy Market Size by Country
9.3.1 South America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
9.3.2 Brazil Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
9.3.3 Argentina Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2030)
10.3.2 Turkey Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
10.3.4 UAE Breast Cancer Liquid Biopsy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Breast Cancer Liquid Biopsy Market Drivers
11.2 Breast Cancer Liquid Biopsy Market Restraints
11.3 Breast Cancer Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Breast Cancer Liquid Biopsy Industry Chain
12.2 Breast Cancer Liquid Biopsy Upstream Analysis
12.3 Breast Cancer Liquid Biopsy Midstream Analysis
12.4 Breast Cancer Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Breast Cancer Liquid Biopsy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Breast Cancer Liquid Biopsy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. QIAGEN Company Information, Head Office, and Major Competitors
Table 6. QIAGEN Major Business
Table 7. QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
Table 8. QIAGEN Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. QIAGEN Recent Developments and Future Plans
Table 10. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
Table 13. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Diagnostics Recent Developments and Future Plans
Table 15. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 16. Bio-Rad Laboratories Major Business
Table 17. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
Table 18. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bio-Rad Laboratories Recent Developments and Future Plans
Table 20. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 21. Myriad Genetics Major Business
Table 22. Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
Table 23. Myriad Genetics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Myriad Genetics Recent Developments and Future Plans
Table 25. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 26. Menarini Silicon Biosystems Major Business
Table 27. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
Table 28. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 30. Genomic Health Company Information, Head Office, and Major Competitors
Table 31. Genomic Health Major Business
Table 32. Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
Table 33. Genomic Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Genomic Health Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
Table 38. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Illumina Company Information, Head Office, and Major Competitors
Table 41. Illumina Major Business
Table 42. Illumina Breast Cancer Liquid Biopsy Product and Solutions
Table 43. Illumina Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Illumina Recent Developments and Future Plans
Table 45. Biocept Company Information, Head Office, and Major Competitors
Table 46. Biocept Major Business
Table 47. Biocept Breast Cancer Liquid Biopsy Product and Solutions
Table 48. Biocept Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biocept Recent Developments and Future Plans
Table 50. Trovagene Company Information, Head Office, and Major Competitors
Table 51. Trovagene Major Business
Table 52. Trovagene Breast Cancer Liquid Biopsy Product and Solutions
Table 53. Trovagene Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Trovagene Recent Developments and Future Plans
Table 55. Guardant Health Company Information, Head Office, and Major Competitors
Table 56. Guardant Health Major Business
Table 57. Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
Table 58. Guardant Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Guardant Health Recent Developments and Future Plans
Table 60. RainDance Technologies Company Information, Head Office, and Major Competitors
Table 61. RainDance Technologies Major Business
Table 62. RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
Table 63. RainDance Technologies Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. RainDance Technologies Recent Developments and Future Plans
Table 65. MDx Health Company Information, Head Office, and Major Competitors
Table 66. MDx Health Major Business
Table 67. MDx Health Breast Cancer Liquid Biopsy Product and Solutions
Table 68. MDx Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. MDx Health Recent Developments and Future Plans
Table 70. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Players (2019-2024)
Table 71. Global Breast Cancer Liquid Biopsy Revenue Share by Players (2019-2024)
Table 72. Breakdown of Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Breast Cancer Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Breast Cancer Liquid Biopsy Players
Table 75. Breast Cancer Liquid Biopsy Market: Company Product Type Footprint
Table 76. Breast Cancer Liquid Biopsy Market: Company Product Application Footprint
Table 77. Breast Cancer Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 78. Breast Cancer Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Breast Cancer Liquid Biopsy Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Breast Cancer Liquid Biopsy Consumption Value Share by Type (2019-2024)
Table 81. Global Breast Cancer Liquid Biopsy Consumption Value Forecast by Type (2025-2030)
Table 82. Global Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024)
Table 83. Global Breast Cancer Liquid Biopsy Consumption Value Forecast by Application (2025-2030)
Table 84. North America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Breast Cancer Liquid Biopsy Raw Material
Table 115. Key Suppliers of Breast Cancer Liquid Biopsy Raw Materials
Table 1. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Breast Cancer Liquid Biopsy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Breast Cancer Liquid Biopsy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. QIAGEN Company Information, Head Office, and Major Competitors
Table 6. QIAGEN Major Business
Table 7. QIAGEN Breast Cancer Liquid Biopsy Product and Solutions
Table 8. QIAGEN Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. QIAGEN Recent Developments and Future Plans
Table 10. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics Major Business
Table 12. Roche Diagnostics Breast Cancer Liquid Biopsy Product and Solutions
Table 13. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Diagnostics Recent Developments and Future Plans
Table 15. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 16. Bio-Rad Laboratories Major Business
Table 17. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product and Solutions
Table 18. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bio-Rad Laboratories Recent Developments and Future Plans
Table 20. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 21. Myriad Genetics Major Business
Table 22. Myriad Genetics Breast Cancer Liquid Biopsy Product and Solutions
Table 23. Myriad Genetics Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Myriad Genetics Recent Developments and Future Plans
Table 25. Menarini Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 26. Menarini Silicon Biosystems Major Business
Table 27. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product and Solutions
Table 28. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Menarini Silicon Biosystems Recent Developments and Future Plans
Table 30. Genomic Health Company Information, Head Office, and Major Competitors
Table 31. Genomic Health Major Business
Table 32. Genomic Health Breast Cancer Liquid Biopsy Product and Solutions
Table 33. Genomic Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Genomic Health Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product and Solutions
Table 38. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Illumina Company Information, Head Office, and Major Competitors
Table 41. Illumina Major Business
Table 42. Illumina Breast Cancer Liquid Biopsy Product and Solutions
Table 43. Illumina Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Illumina Recent Developments and Future Plans
Table 45. Biocept Company Information, Head Office, and Major Competitors
Table 46. Biocept Major Business
Table 47. Biocept Breast Cancer Liquid Biopsy Product and Solutions
Table 48. Biocept Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Biocept Recent Developments and Future Plans
Table 50. Trovagene Company Information, Head Office, and Major Competitors
Table 51. Trovagene Major Business
Table 52. Trovagene Breast Cancer Liquid Biopsy Product and Solutions
Table 53. Trovagene Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Trovagene Recent Developments and Future Plans
Table 55. Guardant Health Company Information, Head Office, and Major Competitors
Table 56. Guardant Health Major Business
Table 57. Guardant Health Breast Cancer Liquid Biopsy Product and Solutions
Table 58. Guardant Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Guardant Health Recent Developments and Future Plans
Table 60. RainDance Technologies Company Information, Head Office, and Major Competitors
Table 61. RainDance Technologies Major Business
Table 62. RainDance Technologies Breast Cancer Liquid Biopsy Product and Solutions
Table 63. RainDance Technologies Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. RainDance Technologies Recent Developments and Future Plans
Table 65. MDx Health Company Information, Head Office, and Major Competitors
Table 66. MDx Health Major Business
Table 67. MDx Health Breast Cancer Liquid Biopsy Product and Solutions
Table 68. MDx Health Breast Cancer Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. MDx Health Recent Developments and Future Plans
Table 70. Global Breast Cancer Liquid Biopsy Revenue (USD Million) by Players (2019-2024)
Table 71. Global Breast Cancer Liquid Biopsy Revenue Share by Players (2019-2024)
Table 72. Breakdown of Breast Cancer Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Breast Cancer Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 74. Head Office of Key Breast Cancer Liquid Biopsy Players
Table 75. Breast Cancer Liquid Biopsy Market: Company Product Type Footprint
Table 76. Breast Cancer Liquid Biopsy Market: Company Product Application Footprint
Table 77. Breast Cancer Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 78. Breast Cancer Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Breast Cancer Liquid Biopsy Consumption Value (USD Million) by Type (2019-2024)
Table 80. Global Breast Cancer Liquid Biopsy Consumption Value Share by Type (2019-2024)
Table 81. Global Breast Cancer Liquid Biopsy Consumption Value Forecast by Type (2025-2030)
Table 82. Global Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024)
Table 83. Global Breast Cancer Liquid Biopsy Consumption Value Forecast by Application (2025-2030)
Table 84. North America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 85. North America Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 86. North America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 87. North America Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 88. North America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 89. North America Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Europe Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Europe Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 97. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 98. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 99. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 100. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2019-2024) & (USD Million)
Table 101. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value by Region (2025-2030) & (USD Million)
Table 102. South America Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 103. South America Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 104. South America Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 105. South America Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 106. South America Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 107. South America Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2019-2024) & (USD Million)
Table 109. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Type (2025-2030) & (USD Million)
Table 110. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2019-2024) & (USD Million)
Table 111. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Application (2025-2030) & (USD Million)
Table 112. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2019-2024) & (USD Million)
Table 113. Middle East & Africa Breast Cancer Liquid Biopsy Consumption Value by Country (2025-2030) & (USD Million)
Table 114. Breast Cancer Liquid Biopsy Raw Material
Table 115. Key Suppliers of Breast Cancer Liquid Biopsy Raw Materials
LIST OF FIGURES
Figure 1. Breast Cancer Liquid Biopsy Picture
Figure 2. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
Figure 4. Circulating Tumor Cells (CTCs)
Figure 5. Cell-Free DNA (CfDNA)
Figure 6. Extracellular Vesicles (EVs)
Figure 7. Other Circulating Biomarkers
Figure 8. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Breast Cancer Liquid Biopsy Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Diagnostic Centers Picture
Figure 12. Laboratories Picture
Figure 13. Global Breast Cancer Liquid Biopsy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Breast Cancer Liquid Biopsy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Breast Cancer Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Region in 2023
Figure 18. North America Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Breast Cancer Liquid Biopsy Revenue Share by Players in 2023
Figure 24. Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Breast Cancer Liquid Biopsy Market Share in 2023
Figure 26. Global Top 6 Players Breast Cancer Liquid Biopsy Market Share in 2023
Figure 27. Global Breast Cancer Liquid Biopsy Consumption Value Share by Type (2019-2024)
Figure 28. Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2025-2030)
Figure 29. Global Breast Cancer Liquid Biopsy Consumption Value Share by Application (2019-2024)
Figure 30. Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2025-2030)
Figure 31. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 41. France Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Region (2019-2030)
Figure 48. China Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 51. India Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 65. Breast Cancer Liquid Biopsy Market Drivers
Figure 66. Breast Cancer Liquid Biopsy Market Restraints
Figure 67. Breast Cancer Liquid Biopsy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Breast Cancer Liquid Biopsy in 2023
Figure 70. Manufacturing Process Analysis of Breast Cancer Liquid Biopsy
Figure 71. Breast Cancer Liquid Biopsy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Breast Cancer Liquid Biopsy Picture
Figure 2. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Type in 2023
Figure 4. Circulating Tumor Cells (CTCs)
Figure 5. Cell-Free DNA (CfDNA)
Figure 6. Extracellular Vesicles (EVs)
Figure 7. Other Circulating Biomarkers
Figure 8. Global Breast Cancer Liquid Biopsy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Breast Cancer Liquid Biopsy Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Diagnostic Centers Picture
Figure 12. Laboratories Picture
Figure 13. Global Breast Cancer Liquid Biopsy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Breast Cancer Liquid Biopsy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Market Breast Cancer Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 16. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Region (2019-2030)
Figure 17. Global Breast Cancer Liquid Biopsy Consumption Value Market Share by Region in 2023
Figure 18. North America Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 20. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 21. South America Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 22. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 23. Global Breast Cancer Liquid Biopsy Revenue Share by Players in 2023
Figure 24. Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 25. Global Top 3 Players Breast Cancer Liquid Biopsy Market Share in 2023
Figure 26. Global Top 6 Players Breast Cancer Liquid Biopsy Market Share in 2023
Figure 27. Global Breast Cancer Liquid Biopsy Consumption Value Share by Type (2019-2024)
Figure 28. Global Breast Cancer Liquid Biopsy Market Share Forecast by Type (2025-2030)
Figure 29. Global Breast Cancer Liquid Biopsy Consumption Value Share by Application (2019-2024)
Figure 30. Global Breast Cancer Liquid Biopsy Market Share Forecast by Application (2025-2030)
Figure 31. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 32. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 33. North America Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 34. United States Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 35. Canada Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 36. Mexico Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 37. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 38. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 39. Europe Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 40. Germany Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 41. France Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 42. United Kingdom Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 43. Russia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 44. Italy Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 45. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 46. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 47. Asia-Pacific Breast Cancer Liquid Biopsy Consumption Value Market Share by Region (2019-2030)
Figure 48. China Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 49. Japan Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 50. South Korea Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 51. India Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 52. Southeast Asia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 53. Australia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 54. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 55. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 56. South America Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 57. Brazil Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 58. Argentina Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 59. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Type (2019-2030)
Figure 60. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Application (2019-2030)
Figure 61. Middle East and Africa Breast Cancer Liquid Biopsy Consumption Value Market Share by Country (2019-2030)
Figure 62. Turkey Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 63. Saudi Arabia Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 64. UAE Breast Cancer Liquid Biopsy Consumption Value (2019-2030) & (USD Million)
Figure 65. Breast Cancer Liquid Biopsy Market Drivers
Figure 66. Breast Cancer Liquid Biopsy Market Restraints
Figure 67. Breast Cancer Liquid Biopsy Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Breast Cancer Liquid Biopsy in 2023
Figure 70. Manufacturing Process Analysis of Breast Cancer Liquid Biopsy
Figure 71. Breast Cancer Liquid Biopsy Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
